study today american journal psychiatry indicated effect guanfacine tenex treating ptsd go benefit several adverse side effects says lead author thomas neylan md medical director ptsd treatment program sfvamc people symptoms ptsd probably stay away drug others type snip guanfacine clonidine another alpha agonist commonly prescribed ptsd symptoms snip double blind study compared effects guanfacine identical looking placebo pill male female veterans four va medical centers california hawaii twenty nine participants randomly assigned take weekly doses drug assigned placebo eight weeks end study effect guanfacine ptsd symptoms zero differences men women older versus younger veterans addition subjects took guanfacine significantly somnolence lightheadedness dry mouth took placebo study authors conclude results support use alpha agonists veterans chronic ptsd press release source part closer look forbes good story turn starting snippet article guanfacine clonidine alpha agonists means bind alpha receptor brain cells blocking release neurotransmitter called norepinephrine neylan study author explained norepinephrine neural form stress hormone adrenalin psychiatrists long known ptsd patients increased levels norepinephrine activity brains start whole idea appealing give drug like guanfacine blocks effects norepinephrine hope see benefit said made intuitive sense lovely idea fact attractive idea review articles guidelines published variety psychiatric journals touted use guanfacine clonidine easing ptsd symptoms one ever put idea test randomized controlled trial woah hold review articles guidelines pimped treatment never tested controlled clinical trial friends synopsis wrong psychiatry treatment face evidence let me qualify treatments work reasonably well polypharmacy highly abundant real world practice despite precious little supportive evidence label prescriptions fine supportive evidence perhaps data supported treatments failed know much label label prescribing done without eye toward clinical trial data honestly even possible many articles recommend treatment never subjected basic scientific scrutiny making me think neurontin switch positive note i happy see trial showing efficacy published ajp congratulations nice negative study buried blunt talk authors also appreciated course one could take view trial showing appropriate assay sensitivity count evidence thus negative trials published i talking read